Print（PDF/104KB） May 12, 2021 Corporate

Sumitomo Dainippon Pharma Announces Changes in Board of Directors and Audit & Supervisory Board

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) announced today that in its meeting held on May 12, 2021, the Board of Directors appointed the following candidates for new members of the Board of Directors as well as the Audit & Supervisory Board.

1. Change in the Members of the Board of Directors (as of June 24, 2021)

(1) New Member of the Board of Directors
Minoru Usui (currently Chairman and Director, Seiko Epson Corporation)
Note: The new member of the Board of Directors who will take office as of June 24, 2021 is subject to the approval at the general shareholders' meeting scheduled for the same date.
Minoru Usui is a candidate for Outside Director.

2. Changes in the Members of the Audit & Supervisory Board (as of June 24, 2021)

(1) New Member of the Audit & Supervisory Board
Mayumi Mochizuki (currently Professor Emeritus, Keio University)
Note: The new member of the Audit & Supervisory Board who will take office as of June 24, 2021 is subject to the approval at the general shareholders' meeting scheduled for the same date.
Mayumi Mochizuki is a candidate for Outside Audit & Supervisory Board Member.

(2) Retiring Member of the Audit & Supervisory Board
Kazuto Nishikawa (currently Outside Audit & Supervisory Board Member)

(Reference)
Brief Personal History of the candidates for new members of the Board of Directors and the Audit & Supervisory Board

1. Brief Personal History of the candidate for new member of the Board of Directors

(1) Minoru Usui (Mr.) Birthdate: April 22, 1955
Nov. 1979
 Joined Shinshu Seiki Co., Ltd. (currently Seiko Epson Corporation)
June 2002
 Director, Seiko Epson Corporation
Nov. 2005
 General Administrative Manager, Production Engineering & Development Division, Seiko Epson Corporation
July 2007
 General Administrative Manager, Corporate Research & Development Division, Seiko Epson Corporation
Oct. 2007
 Managing Director, Seiko Epson Corporation
June 2008
 President and Representative Director, Seiko Epson Corporation
Chief Executive Officer, Seiko Epson Corporation
April 2020
 Chairman and Director, Seiko Epson Corporation (up to the present)

2. Brief Personal History of the candidate for new member of the Audit & Supervisory Board

(1) Mayumi Mochizuki (Ms.) Birthdate: March 10, 1954
April 1976
 Joined Nippon Roche K.K. (currently Chugai Pharmaceutical Co., Ltd.)
April 1983
 Department of Pharmacy, Kitasato University Hospital
April 1997
 Associate Professor, Graduate School of Pharmaceutical Sciences, Chiba University
Sept. 2000
 Professor, School of Pharmacy, Kitasato University
April 2007
 Professor, Kyoritsu University of Pharmacy
April 2008
 Professor, Faculty of Pharmacy, Keio University
April 2009
 Associate Dean in Pharmacy, Graduate School of Pharmaceutical Sciences, Keio University
July 2013
 Dean, Faculty of Pharmacy; Dean, Graduate School of Pharmaceutical Sciences, Keio University
Oct. 2015
 Director, Department of Pharmacy, Keio University Hospital
April 2019
 Professor Emeritus, Keio University (up to the present)
April 2019
 Project Professor, Faculty of Pharmacy, Keio University
April 2019
 Adviser, International Medical Information Center (up to the present)
April 2020
 Special Adviser, International University of Health and Welfare (up to the present)
Oct. 2020
 Vice President, Science Council of Japan (up to the present)
To the top of News Room

Inquiries from the Press